Literature DB >> 7865168

Effect of dizocilpine (MK-801) on the catalepsy induced by delta 9-tetrahydrocannabinol in mice.

H Kinoshita1, T Hasegawa, Y Katsumata, T Kameyama, I Yamamoto, T Nabeshima.   

Abstract

Mice treated with delta 9-tetrahydrocannabinol (THC; 5 and 10 mg/kg i.v.) showed the catalepsy in high bar test, and median descent latencies of catalepsy were about 150 sec. Dizocilpine (MK-801, 0.05 and 0.1 mg/kg), non-competitive N-methyl-D-aspartate (NMDA) antagonist, significantly attenuated THC-induced catalepsy. Furthermore, the anticataleptic effect of MK-801 on THC-induced catalepsy was blocked by acetylcholine agonist oxotremorine (0.005 mg/kg) and dopamine antagonist haloperidol (0.01 mg/kg), but not by NMDA. Oxotremorine, haloperidol, and NMDA themselves did not affect THC-induced catalepsy at the doses used. These results suggest that the anticataleptic effect of MK-801 on THC-induced catalepsy may be developed through dopaminergic and acetylcholinergic neuronal systems.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865168     DOI: 10.1007/bf01276432

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  19 in total

1.  Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

Authors:  M Herkenham; A B Lynn; B R de Costa; E K Richfield
Journal:  Brain Res       Date:  1991-05-03       Impact factor: 3.252

2.  Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen.

Authors:  B Costall; J E Olley
Journal:  Neuropharmacology       Date:  1971-05       Impact factor: 5.250

3.  [Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats].

Authors:  M Fujiwara; Y Sakurai; Y Kiyota; T Shimazoe; H Ohta; S Shibata; S Ueki
Journal:  Nihon Yakurigaku Zasshi       Date:  1985-04

4.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

5.  Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems.

Authors:  M Carlsson; A Svensson
Journal:  Pharmacol Biochem Behav       Date:  1990-05       Impact factor: 3.533

6.  Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

Authors:  P K Sonsalla; W J Nicklas; R E Heikkila
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

7.  Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.

Authors:  A Lupp; C H Lücking; R Koch; R Jackisch; T J Feuerstein
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

8.  MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis.

Authors:  M Hasegawa; H Kinoshita; M Amano; T Hasegawa; T Kameyama; T Nabeshima
Journal:  Neurosci Lett       Date:  1993-02-05       Impact factor: 3.046

9.  Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.

Authors:  S M Papa; T M Engber; R C Boldry; T N Chase
Journal:  Eur J Pharmacol       Date:  1993-03-02       Impact factor: 4.432

10.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

View more
  3 in total

1.  Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.

Authors:  Deepak Cyril D'Souza; Gabriel Braley; Rebecca Blaise; Michael Vendetti; Stephen Oliver; Brian Pittman; Mohini Ranganathan; Savita Bhakta; Zoran Zimolo; Thomas Cooper; Edward Perry
Journal:  Psychopharmacology (Berl)       Date:  2008-01-29       Impact factor: 4.530

2.  Synthesis and Evaluation of Phenylxanthine Derivatives as Potential Dual A2AR Antagonists/MAO-B Inhibitors for Parkinson's Disease.

Authors:  Xuebao Wang; Chao Han; Yong Xu; Kaiqi Wu; Shuangya Chen; Mangsha Hu; Luyao Wang; Yun Ye; Faqing Ye
Journal:  Molecules       Date:  2017-06-17       Impact factor: 4.411

3.  Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice.

Authors:  Omar M E Abdel-Salam; Marawa El-Sayed El-Shamarka; Neveen A Salem; Alaa El-Din M Gaafar
Journal:  EXCLI J       Date:  2012-02-24       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.